Project Mercury
Hace 20 horas
martes, 30 de septiembre de 2025
Viewpoints: A Formula For Fixing A Public Health System In Crisis; For Many, Vaccine Hesitancy Feels Logical
https://kffhealthnews.org/morning-breakout/viewpoints-a-formula-for-fixing-a-public-health-system-in-crisis-for-many-vaccine-hesitancy-feels-logical/
Viewpoints: A Formula For Fixing A Public Health System In Crisis; For Many, Vaccine Hesitancy Feels Logical
Opinion writers discuss these public health issues.
Stat: How To Respond To Dangerous Changes To U.S. Public Health
A dangerous idea is on the table: ending universal hepatitis B birth-dose vaccination in the United States. For many years, the Centers for Disease Control and Prevention has recommended that every baby born in this country receive the vaccine, preventing infections and deaths from a disease that causes liver cancer and deadly cirrhosis. (Most other higher-income countries have the same recommendation.) Abandoning this protection would condemn thousands of children every year to lifelong infection. One in four babies infected at birth eventually die from this preventable infection. (Tom Frieden, 9/30)
The New York Times: What Really Drives Vaccine Hesitancy
In the 20 years I’ve spent researching vaccine decisions, I have spoken to plenty of parents who reject shots for their children. Some say vaccines are never safe or necessary or that polio went away on its own and the vaccine wrongly got credit. I’ve heard comparisons of vaccines to snake venom. In reality, however, the number of people who reject all vaccines is quite small — so small that they are unlikely to compromise public health. (Jennifer Reich, 9/30)
Stat: What Are The Ethical Implications Of Saving A Single Child's Life?
He was two months old and already living on borrowed time. The baby, born in El Salvador, had never drawn a breath on his own. His rare congenital condition narrowed the airway deep within his chest. A ventilator kept him alive. A breathing tube threaded down his throat had become his surrogate airway. But that tube, and that machine, were reaching their limits. The baby’s oxygen levels were harder to maintain. Infections loomed. Without surgery to reconstruct his airway, he would not survive another month. (Christopher Hartnick, 9/30)
Kansas City Star: Missouri's Abortion Amendment Language Hides True Intent
Everything you need to know about the latest effort to ban abortion in Missouri comes down to this: Republicans don’t actually want voters to know they’re going to ban abortion. Again. They’re trying to sneak it past you. (Joel Mathis, 9/29)
Stat: Insurance Companies Are On A New Slippery Slope: Downcoding
Insurance companies continue to innovate. On Oct. 1, Cigna will roll out a policy that tracks how physicians bill. It will flag those who submit a higher proportion of level four or level five visits — which get reimbursed at a higher rate — than their peers. For doctors placed under this extra scrutiny, certain claims at those higher levels may be adjusted down by one level if the billing details do not appear to justify the service. The affected codes include 99204–99205 (new patient, office/outpatient), 99214–99215 (established patient, office/outpatient), and 99244–99245 (consultations). (Ryan Nadelson, 9/29)
West Nile Cases Up; Many People Don’t Know The Right Way To Use Bug Spray
https://kffhealthnews.org/morning-breakout/west-nile-cases-up-many-people-dont-know-the-right-way-to-use-bug-spray/
West Nile Cases Up; Many People Don’t Know The Right Way To Use Bug Spray
Colorado has more than double the cases of West Nile virus of any other state, the CDC says. But the virus — spread by mosquitoes — is also on the rise in Massachusetts, Rhode Island, and elsewhere. Concerningly, most Americans don't know how to properly apply mosquito repellant, a poll shows.
9news.com: West Nile Cases, Deaths Continue To Climb In Colorado
West Nile virus cases are climbing higher in Colorado. According to the Colorado Department of Public Health and Environment, Colorado has had 235 cases of West Nile this year. Twelve people have died. Data from the Centers for Disease Control and Prevention shows Colorado has more than double the cases of any other state. (Krause, 9/28)
Boston.com: Mass. Health Officials Announce Additional Human Cases Of West Nile Virus
State health officials on Friday announced two new human cases of West Nile virus in Massachusetts this year. According to the Massachusetts Department of Public Health (DPH), one case involves a woman in her 60s who was exposed to the mosquito-borne illness in Middlesex County. The second case involves a man in his 50s who was exposed in Suffolk County. These bring the total number of confirmed human cases of West Nile Virus this season to eight. (Rousseau, 9/27)
Rhode Island Current: R.I. Reports First Probable Human Case Of West Nile Of 2025
A Providence County resident in their 60s is the first probable human case of West Nile virus in Rhode Island this year, the state Department of Health announced Thursday. The case will be confirmed through further testing by the U.S. Centers for Disease Control and Prevention (CDC). Health officials did not disclose where the person was exposed, but said they began showing symptoms in early September and have remained hospitalized since. (Shea, 9/25)
CIDRAP: US Poll Shows West Nile Anxiety Low, As Is Insect Repellent Knowledge
A new Annenberg poll finds that, despite an increase in US infections, worry about West Nile virus remains low among Americans, and most people don't know how to correctly apply insect repellent in certain situations. West Nile is the leading mosquito-borne illness in the continental United States, and the Centers for Disease Control and Prevention (CDC) has tracked 1,137 cases so far in 2025 in 42 states. (Soucheray, 9/29)
More health and wellness news —
Newsweek: Why Millennials Need To Rethink Eye Care To Avoid Blindness
If you're in your 20s or 30s, eye disease or vision care might not be high on your list of priorities. But experts warn that this is exactly the time to start protecting your sight to avoid serious problems later in life. Newsweek spoke to two leading eye specialists who explained how everyday lifestyle choices can set the stage for poor eye health—and what you can do now to prevent blindness in the future. (Notarantonio, 9/29)
Stat: Why Risk Factors Matter: 99% Of Heart Attack, Stroke Victims, Had One
Heart attacks, heart failure, and strokes don’t come out of nowhere, a new study concludes. The first time they strike, patients, clinicians, and researchers might think there were no red flags. But a prospective cohort study reports that more than 99% of people who experienced these illnesses had at least one of four risks for cardiovascular disease. (Cooney, 9/29)
Newsweek: Chemical Body Odors May Help Detect Cancers Early
Volatile chemicals released by the body—through urine, feces and odor—could one day help to noninvasively detect cancer early. In mouse models, researchers at Hefei Institutes of Physical Science of the Chinese Academy of Sciences found volatile organic compounds (VOCs) could offer helpful clues in screening for multiple types of cancer at once. (Millington, 9/29)
The New York Times: ‘Kpop Demon Hunters’ Noodle Cup Trend May Increase Burn Risks For Kids
TikTok users have rushed to get their hands on the instant noodles that appear in the film. One prominent Boston hospital has sounded the alarm. Dr. Colleen Ryan, a doctor at the hospital, said in the statement that she had been treating children two to three times a week for burn injuries from instant noodles. Even before the movie, burn injuries from instant noodles made up almost a third of overall pediatric scald burn injuries, according to a study. (Young, 9/29)
AP: Arkansas Egg Producer Recalls Eggs Over Salmonella Contamination Risk
An Arkansas egg producer is recalling 12-count and 18-count cartons of free-range large brown eggs after federal health inspectors detected salmonella contamination at a processing site. ... The move came after U.S. Food and Drug Administration inspectors collected samples from the processing site and found 40 that were positive for salmonella bacteria. Seven different strains of salmonella were identified, including some known to cause human illness. (Aleccia, 9/29)
KFF Health News: KFF Health News’ ‘Letters To The Editor’: Readers Speak Up For Patients Who Can't, And For Kids With Disabilities
Too Close a Call With Organ Donation. When I was a third-year med student doing a rotation on the trauma surgery team, we had a patient in the surgical intensive care unit who had arrived 12 hours earlier with bullet holes in his abdomen. We worked to stabilize him all night; the next day, he was still alive. (9/30)
New Report Shows Notable Decline In Clinical Abortions In First Half Of Year
https://kffhealthnews.org/morning-breakout/new-report-shows-notable-decline-in-clinical-abortions-in-first-half-of-year/
New Report Shows Notable Decline In Clinical Abortions In First Half Of Year
According to Guttmacher Institute data, the decline is greatest in states with six-week bans as well as states bordering those with full bans. An 8% decline in out-of-state travel for care also was reported.
CNN: Abortions Provided By Clinicians In The US Dropped In The First Half Of 2025, Report Shows
The number of abortions provided by clinicians in the United States has declined this year as the effects of new restrictions bear out and it becomes more common to manage an abortion outside the formal health care system, a new report suggests. (McPhillips, 9/30)
In other reproductive health news —
AP: California Doctor Is 2nd To Face Louisiana Arrest Warrant Over Abortion Pills
Louisiana is pursuing a criminal case against another out-of-state doctor accused of mailing abortion pills to a patient in the state, court documents filed this month revealed. A warrant for the arrest of a California doctor is a rare charge of violating one of the state abortion bans that has taken effect since the U.S. Supreme Court overturned Roe v. Wade in 2022 and allowed enforcement. (Cline and Mulvihill, 9/30)
San Francisco Chronicle: California Catholic Hospitals Sued — Emergency Abortion Denial Alleged
A Northern California woman was twice denied an emergency abortion and sent home after Dignity Health doctors determined her pregnancy wasn’t viable but could not provide the procedure due to Dignity’s religious restrictions, according to a lawsuit filed Friday in San Francisco County Superior Court. In one instance, she developed life-threatening sepsis, the suit said. Rachel Harrison, 30, of Carmichael (Sacramento County), alleges she lost both pregnancies at 17 weeks’ gestation after her water broke and her amniotic fluid was lost. (Gafni, 9/29)
AP: Student Activists Go Underground At Catholic Colleges To Provide Contraception
College student Maya Roman has the handoff down to a science: a text message, a walk to a designated site, and a paper bag delivered with condoms and Plan B emergency contraception. At DePaul University, it’s the only way students can get a sliver of sexual health support, she said. DePaul, a Catholic school in Chicago, prohibits distribution of any kind of birth control on its campus. To get around that, a student group runs a covert contraceptive delivery network called “the womb service.” (Fernando, 9/30)
On sports physicals —
The Nevada Independent: Physicians: Rule That Doctors ID Athlete’s Sex At Birth ‘Inappropriate’ For School Physical
Pediatricians and advocates urged the Nevada Interscholastic Activities Association (NIAA) to remove a new requirement on sports physical evaluations that physicians identify a student’s birth sex and recommend whether they should play boys’ or girls’ sports, calling it “medically inappropriate.” The request came in the form of a letter signed by 18 doctors and medical professionals sent via email last week to Executive Director Timothy Jackson, who leads the association that governs high school sports in Nevada. (Mueller and Hernandez, 9/29)
More health care updates from across the U.S. —
Politico: Gavin Newsom Signs First-In-Nation AI Safety Law
California Gov. Gavin Newsom signed a first-in-the-nation law on Monday that will force major AI companies to reveal their safety protocols — marking the end of a lobbying battle with big tech companies like ChatGPT maker OpenAI and Meta and setting the groundwork for a potential national standard. (DeFeliciantonio, 9/29)
MedPage Today: 'We Are Exhausted, Frustrated, And Sad': Docs Vent During Meeting With Senator
Sen. Tim Kaine (D-Va.), a member of the Senate health committee, heard from a variety of providers Monday about their frustrations with the healthcare system. "We are exhausted, frustrated, and sad, and trying to claw our way back up there," said Ashley Zelenak, MD, a pediatric emergency physician at Bon Secours St. Mary's Hospital in Richmond, Virginia. "We took such a hit during COVID and now to be hit [again] as a pediatrician, it's hard." (Frieden, 9/29)
Modesto Bee: Funding Crisis May Close Modesto's Homeless Shelter ACES
It can’t be good news for anyone encouraged by tiny home projects or other recent developments to assist the homeless. Stanislaus County has sent a six-month notice to end an agreement with The Salvation Army for operation of the low-barrier homeless shelter on D Street in Modesto. Closing the facility would remove 182 shelter beds for people who don’t have a home. (Carlson, 9/28)
AP: Seattle Bakers Donate Homemade Bread To Help Fight Hunger
On a recent Saturday near Seattle, Cheryl Ewaldsen pulled three golden loaves of wheat bread out of her kitchen oven. The fragrant, oat-topped bread was destined not for her table, but for a local food bank, to be distributed to families increasingly struggling with hunger and the high cost of groceries. ... Ewaldsen is a volunteer with Community Loaves, a Seattle-area nonprofit that started pairing home bakers with food pantries during the COVID-19 pandemic — and hasn’t stopped. (Aleccia, 9/29)
Opioid Use Disorder Diagnoses Surged Nationwide Between 2021 And 2024
https://kffhealthnews.org/morning-breakout/opioid-use-disorder-diagnoses-surged-nationwide-between-2021-and-2024/
Opioid Use Disorder Diagnoses Surged Nationwide Between 2021 And 2024
Tennessee had the highest rate, with 1,447 patients diagnosed with opioid use disorder per 100,000, Axios reports. Also in the news: Gabapentin use rises, GLP-1 meds are tied to lower cancer risk, and more.
Axios: Opioid Use Disorder Cases Jumped Post-Pandemic
Diagnoses of opioid use disorder among the commercially insured jumped nearly 40% nationwide between 2021 and 2024, according to data from FAIR Health's Opioid Tracker shared first with Axios. (Reed, 9/30)
More pharmaceutical news —
MedPage Today: Gabapentin Use Skyrockets Despite Risks, CDC Analysis Shows
Gabapentin prescribing rose sharply in recent years, with the generic drug becoming the fifth most dispensed product in retail pharmacies in 2024, a CDC analysis showed. From 2010 to 2024, prescriptions jumped from 79.5 to 177.6 per 1,000 people, according to Gery Guy Jr., PhD, of the CDC National Center for Injury Prevention and Control, and co-authors. (George, 8/29)
Fox News: GLP-1 Drugs Linked To Lower Cancer Risk, Particularly In Women, New Study Finds
The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are associated with a reduced risk of some cancers, especially in women. (Stabile, 9/29)
CIDRAP: Inhaled Heparin Slashes Ventilation, Death In COVID Patients, Analysis Suggests
A meta-trial of randomized clinical studies conducted in 6 countries suggests that the use of inhaled heparin dramatically reduced the risk of intubation, death, and in-hospital death in hospitalized COVID-19 patients. (Van Beusekom, 9/29)
In health care industry news —
Modern Healthcare: UHS To Pay $500M In Prime Healthcare Lawsuit
Universal Health Services faces more than $500 million in damages after a Nevada jury ruled the system had interfered with Prime Healthcare physicians’ contracts. The lawsuit, which was filed in Washoe County, Nevada, in 2021, stems from Prime’s allegations that UHS illegally solicited physicians and other employees from Saint Mary’s Medical Group, stole trade secrets, diverted patients and triggered a mass resignation to gain an economic advantage, according to a Monday press release from Prime. (Hudson, 9/29)
The CT Mirror: Yale To Pay Prospect Medical $45M To End Hospital Sale Dispute
Yale New Haven Health will pay Prospect Medical Holdings $45 million to settle dueling lawsuits in state court, ending a contentious saga over the proposed sale of Prospect’s three Connecticut hospitals — with Yale acquiring none of them. (Altimari, 9/29)
KFF Health News: Doctors With Troubled Pasts Are Performing Cosmetic Surgeries Tied To Crippling Pain And Injury
Not long after California surgeon Andrew S. Hsu landed a job with a cosmetic surgery chain in Georgia, several of his patients suffered disfiguring injuries, and even his new employer had doubts about his competence, court records allege. Hsu, a board-certified general surgeon, was one of six out-of-state doctors who joined the Atlanta Goals Aesthetics & Plastic Surgery center during the pandemic. (Schulte, 9/30)
KFF Health News: How To Pick The Right Cosmetic Surgeon
The debate over which doctors are best qualified to perform cosmetic surgery — and who gets the best results for patients — has raged for decades. Here’s why: A state-issued medical license grants a physician what a Federation of State Medical Boards policy statement called the “privilege of practicing the full breadth of medicine.” (Schulte, 9/30)
HHS Moves To Bar Harvard From Receiving Federal Funding, Contracts
https://kffhealthnews.org/morning-breakout/hhs-moves-to-bar-harvard-from-receiving-federal-funding-contracts/
HHS Moves To Bar Harvard From Receiving Federal Funding, Contracts
The university has 20 days to request a hearing to appeal the decision. Plus, the Trump administration says it will defund a federal government watchdog group. In other news: Trump shared a video promoting cannabis use for seniors.
Bloomberg: US Recommends Harvard Be Excluded From Federal Funding, HHS Says
The US Department of Health and Human Services said Monday that it is referring Harvard University for administrative suspension and debarment proceedings, a move that would exclude the school from entering into contracts with all government agencies or receiving any federal funding, including research grants and student aid. If successful, the debarment attempt would cut off a key funding source for Harvard, a fresh financial blow after the Trump administration’s freeze of more than $2.6 billion in existing federal dollars. (Knox, 9/29)
The Washington Post: Trump Administration Moves To Defund Inspector General Watchdog Group
The Trump administration plans to end funding starting Wednesday for an oversight group that helps inspectors general root out waste, fraud and abuse, marking the latest example of Trump’s drive to limit federal watchdog activities. The group — called the Council of the Inspectors General on Integrity and Efficiency — is the umbrella organization for 72 inspectors general across government. It informed four House and Senate committees on Saturday that it would “cease our statutorily mandated functions and furlough 25 permanent employees” without funding, according to a letter obtained by The Washington Post. (Kornfield, 0/30)
The Washington Post: Trump’s USAID Pause Stranded Lifesaving Drugs. Children Died Waiting.
USAID antimalarial and HIV supplies valued at nearly $140 million were delayed in the first half of the year or not delivered at all due to the Trump administration’s foreign aid pause, The Post found. (Kelly, Lee, Ombuor, Blaskey, Tran, Galocha, Lau and Houreld, 9/30)
On prescription drug prices —
The Wall Street Journal: Novartis To Launch Direct-To-Patient Platform For Cosentyx In U.S.
Novartis said it is launching a direct-to-patient platform in the U.S. to sell a discounted version of its Cosentyx drug, the latest big pharma company to move to cut prices ahead of the Trump administration’s deadline. The Swiss pharmaceutical company said Monday that it would offer select units of Cosentyx—a drug treating immune-mediated inflammatory conditions like psoriasis and psoriatic arthritis—at a 55% discount to cash-paying patients with a prescription. The platform will come into effect on Nov. 1. (Look, 9/29)
Politico: Trump’s Strategy To Get Drug Companies To Act Voluntarily Is About To Be Tested
President Donald Trump sent letters to 17 of the world’s largest pharmaceutical companies at the end of July. He demanded that they voluntarily lower U.S. prices for some of their drugs to match what they charge affluent foreign nations. “If you refuse to step up, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices,” he wrote, requesting a response by September 29. (Lim, 9/29)
On Tylenol lawsuits —
NPR: Trump Blaming Tylenol For Autism Boosts Lawsuits Against The Drugmaker
President Trump's announcement last week linking Tylenol with autism could play a role in ongoing legal cases against the company that makes it. One lawyer representing patients who say they were harmed by the drug says his firm has gotten an influx of more than a thousand calls this week from potential new clients asking for information. (Lupkin, 9/29)
On cannabis —
The Guardian: Cannabis Stocks Soar After Trump Shares Video Promoting Drug’s Use For Seniors
Cannabis stocks are on a high after Donald Trump shared a video on Sunday promoting cannabis use for seniors and Medicaid coverage of CBD products. The nearly three-minute-long video, posted on the president’s Truth Social platform, touts the usage of hemp-derived CBD as a “gamechanger” that is a pain and stress reliever for seniors. (Aratani, 9/29)
AP: Vertanical's Drug Made From Marijuana Reduced Back Pain, Study Finds
An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common forms of chronic pain. The 800-patient study by a German drugmaker is the latest evidence of the therapeutic properties of cannabis, which remains illegal under U.S. federal law even as most states have made it available for medical or recreational use. (Perrone, 9/29)
Many States Brace For Grim Aftermath If Congress Can’t Make A Deal On ACA
https://kffhealthnews.org/morning-breakout/many-states-brace-for-grim-aftermath-if-congress-cant-make-a-deal-on-aca/
Many States Brace For Grim Aftermath If Congress Can’t Make A Deal On ACA
Millions of Americans who buy Obamacare would see their monthly premiums skyrocket. In Georgia, expiring subsidies could cause a loss of $3.7 billion in health sector revenue next year.
Atlanta Journal-Constitution: Georgia Health Sector Faces $3.7B Loss As ACA Subsidies End, Forecast Finds
Georgia’s hospitals, doctors and other health businesses stand to lose $3.7 billion in revenue next year alone, if Congress and President Donald Trump allow Affordable Care Act health insurance subsidies to expire in December, a new forecast has found. Georgia’s expected loss of health sector revenue would be among the three largest in the nation, behind only Florida and Texas, according to the study by the Robert Wood Johnson Foundation and the left-leaning Urban Institute. (Hart, 9/29)
Mountain State Spotlight: 60,000 West Virginians Risk Losing Affordable Health Care As Congress Stalls On Subsidies
Ellen Allen, executive director of West Virginians for Affordable Health Care, said more than 60,000 people in the state — including herself — rely on getting their healthcare from the ACA Marketplace Exchange. Without the subsidies, Allen said families could see their health insurance premiums — the amount paid per month — skyrocket by hundreds of dollars. For instance, Allen said she pays $497 per month for her health insurance. Without the tax credit, it would cost her $2,800 a month. (Culvyhouse, 9/30)
WUSF: Here's How ACA Tax Credits Expiring And Medicaid Cuts Could Impact Floridians
Medicaid coverage and enhanced credits in Affordable Care Act plans have been a safety net for many people. In Florida, over 4.3 million people received Medicaid benefits, and more than 4.7 million are enrolled in the ACA for health care coverage. In Florida, about 2 out of 5 people benefit from ACA or Medicaid plans. But that will soon change. (Bowman, 9/30)
North Carolina Health News: NC Aging Advocates Worry About Federal Government Shutdown Effects
The gears of government are turning slower by the day with a gridlocked U.S. Congress, and they’re threatening to seize altogether as another shutdown looms. For North Carolina’s older adults — many enduring the slow grind of aging bodies and shrinking budgets — the prospect feels all too familiar. (Fredde, 9/30)
In related news on Medicaid cuts —
Los Angeles Times: How California Families Are Already Bracing For Looming Medicaid Cuts
Ever since Elijah Maldonado was born at just 29 weeks, he has needed specialty treatments that his family could afford only with publicly funded healthcare. Diagnosed with cerebral palsy as an infant, he spent his first three months at a public hospital in Orange County, where the family lives. Now 7, Elijah receives physical and speech therapy among a host of other services paid for through Medicaid. He relies on a wheelchair funded by the government. An assistant paid for with taxpayer dollars makes sure he’s safe on the bus ride to and from school. (Beason, 9/29)
The CT Mirror: Rising Costs Strain Medicaid In CT – Before Federal Cuts Are Counted
Deep cuts in federal Medicaid assistance aren’t the only threat to health care for needy families and children here. Gov. Ned Lamont’s administration has identified major cost overruns in the entitlement program, known as HUSKY in Connecticut, which has struggled to stay out of the red since 2022. (Phaneuf, 9/30)
KFF Health News: Health Care’s Employment Growth Clouded By Immigration Crackdown, Medicaid Cuts
The health care sector is a bright spot in the economy this year, driving nearly half of the nation’s employment gains, but economists and experts say immigration crackdowns and looming Medicaid cuts pose a threat to future job growth. Employers added 487,000 jobs from January to August, according to the latest nonfarm payroll data from the Bureau of Labor Statistics. The health care sector accounted for 48% of that lackluster growth, expanding by about 232,000 jobs, even though the sector employs only about 11% of workers. (Reese, 9/30)
Modern Healthcare: The Tools Advocate, Ascension Are Using To Ease Medicaid Cuts
Healthcare providers, payers and other companies are facing an uncertain regulatory and political environment in the coming years. Massive reductions in Medicaid funding under President Donald Trump’s tax law, known as H.R. 1, and the looming expiration of the Affordable Care Act premium tax subsidies are among the issues likely to undercut margins and operations. (Dubinsky, Early, Perna and McAuliff, 9/29)
Impasse Over ACA Subsidies Unresolved As Clock Ticks Down Toward Shutdown
https://kffhealthnews.org/morning-breakout/impasse-over-aca-subsidies-unresolved-as-clock-ticks-down-toward-shutdown/
Impasse Over ACA Subsidies Unresolved As Clock Ticks Down Toward Shutdown
A meeting between President Donald Trump and congressional leaders did not bring the sides closer to a deal on funding the federal government. Meanwhile, Republicans have upped the rhetoric, saying Democrats want free health care for unauthorized immigrants, a claim that is not part of the proposal Democrats put forward. Plus, Trump posts a vulgar, AI-generated deepfake on Truth Social.
Fierce Healthcare: No Deal In Sight Following High-Stakes White House Negotiations
President Donald Trump and congressional leaders from both parties exited a high-stakes negotiation meeting Monday afternoon with little optimism a deal could be struck before the end of the month to avoid a government shutdown. "I think we’re heading to a shutdown because the Democrats won’t do the right thing," Vice President J.D. Vance told reporters after the meeting. "I hope they change their mind, but we’re going to see.” Healthcare issues have and continue to be a sticking point of the negotiations, with Democrats demanding an extension of Affordable Care Act (ACA) enhanced premiums set to run dry at the end of the year as well as protections against White House recissions of appropriated funding. (Muoio and Beavins, 9/29)
The New York Times: Explaining The G.O.P.’s Misleading Talking Point On The Looming Shutdown
With Congress at an impasse over federal spending, Republicans have emerged with a new and misleading talking point: Democrats are shutting down the government to fund free health care for unauthorized immigrants. It is a message repeated by Vice President JD Vance, the official X account of Senate Republicans and Speaker Mike Johnson. But the proposal does not provide free health care for unauthorized immigrants. Republicans may be referring to the law changing the eligibility requirements for certain immigrant groups. (Qiu, 9/29)
Politico: Trump Posts Vulgar Deepfake Slam Of Democratic Leaders After White House Meeting
If a government shutdown wasn’t already exceedingly likely, President Donald Trump might have made it a near certainty Monday night. The president posted a vulgar AI-generated deepfake video to his Truth Social slamming the top Democratic leaders — Senate Minority Leader Chuck Schumer and House Minority Leader Hakeem Jeffries — just hours after he hosted the two for an Oval Office meeting. (Hill, 9/29)
Politico: Top Tax-Writing Democrat Open To Negotiating Income Caps For Obamacare Subsidies
The top Democrat on the tax-writing House Ways and Means Committee cracked open the door to negotiating income limits for recipients of health care subsidies set to expire at the end of the year. “I think the question of subsidies for people that are making half a million dollars — I mean, that should be subject to a discussion and negotiation as well, but that shouldn’t become the pretense for shutting down the government,” Rep. Richie Neal of Massachusetts said in a brief interview, though he stressed it’d be “premature” to get too far into the specifics. (Wu, 9/29)
Fierce Healthcare: Telehealth Waivers Expire Oct. 1 As Shutdown Inches Closer
Medicare beneficiaries stand to lose access to two key virtual care programs that the federal government has offered since the start of the pandemic if the government shuts down on Tuesday at midnight. The Medicare telehealth waivers and Acute Hospital at Home (AcHaH) programs are set to expire Oct. 1 unless Congress passes a short-term government funding bill to avert the crisis. (Beavins, 9/29)
Also —
Axios: Government Shutdown: HHS Would Furlough Nearly 32,500 Health Workers
Federal health agencies under Robert F. Kennedy Jr. would furlough more than 40% of their remaining workforce in a government shutdown, according to a contingency plan. Some 32,460 government health workers would be without work at least temporarily under the plan and could lose their jobs if Trump follows through on threats to fire those deemed nonessential in a funding lapse. (Goldman, 9/29)
The New York Times: Here’s How A Government Shutdown Works
In some parts of the federal government, there is an immediate impact. But not every federally funded initiative is at the mercy of Congress’s budgeting standoffs, and even some that are may be able to rely on cash reserves to get through a brief shutdown. Department to department, the impacts vary. The Postal Service, which is self-funded, and Social Security and Medicare benefits, which are considered “mandatory” spending, should keep on going. While most federal workers are likely to be furloughed, those designated as “excepted,” such as active-duty troops, air traffic controllers and federal law enforcement officers, stay on the job, even though they cannot be paid for that work until after the shutdown is over. (Demirjian, 9/30)
The importance of analysing, reporting, and interpreting data according to sex and gender Tues, Oct 21, 2025 14:00 BST
https://www.bigmarker.com/lancet-webinars/the-importance-of-analysing-reporting-and-interpreting-data-according-to-sex-and-gender?utm_bmcr_source=hubspot_email_reg1_publishingexcellence_edi_messagesager&_hsmi=382796538&_hsenc=p2ANqtz-8bF1o_IOr-ASeyq7X-veSrV5Tse1IAXICC4w4yXobwCh_crxdlmuBb2Rth2e26cyFUktowJ-U3PlX6RPhQgZIZSyYqCA&hsCtaAttrib=195606862664
We invite you to our upcoming Lancet Webinars on reporting guidelines at The Lancet Group. These two webinars will explore The Lancet Group's guidance on reporting sex, gender, race, and ethnicity data in your research.
Join our expert editors from across The Lancet Group as they give an introduction to the importance of these types of analyses, describe the requirements of our guidelines, provide examples of well-analysed published research, and discuss practical tips for responding to the guidelines. Each webinar will conclude with a Q&A where our editors will answer your questions.
The importance of analysing, reporting, and interpreting data according to sex and gender
Tues, Oct 21, 2025
14:00 BST
Webinars and Virtual Workshops 2 +...
2025 Hybrid Public Workshop: Artificial Intelligence in Drug and Biological Product Development
Date: Tue, Oct. 7, 2025; 9 a.m. ET
Be a part of a dynamic conversation as leading experts dive into the rapidly evolving role of AI in transforming drug and biological product development — spotlighting the evolving role of AI in advancing the safety, efficacy, and quality of drug and biological product development. Drawing on real-world breakthroughs since the first workshop in 2024, our speakers will address best practices, highlight cross-disciplinary collaborations, and reveal creative strategies to boost data quality, reduce bias, and enhance transparency and performance in AI models. Discover fresh opportunities for partnership and walk away with actionable steps to drive responsible, transformative uses of AI in clinical research and to support regulatory decisions.
https://duke.zoom.us/meeting/register/B3i1Vb8RTb6Vwh3TMW1BXQ?utm_medium=email&utm_source=govdelivery#/registration
Advancing Generic Drug Development: Translating Science to Approval 2025
Day 1: Tue, Oct. 7, 2025; 9 a.m. - 4 p.m. ET
Day 2: Wed, Oct. 8, 2025; 9 a.m. - 3 p.m. ET
Join us for the 2025 Advancing Generic Drug Development Workshop! FDA experts will demonstrate the FDA’s Generic Drug User Fee Amendments (GDUFA) Science and Research Program’s transformative impact on generic drug development, regulation, and approval. Dissect complex scientific challenges in abbreviated new drug applications (ANDAs) alongside FDA experts, and gain insights into GDUFA III progress, GDUFA science and research on complex products and scientific issues related to product-specific guidance development, as well as pre-ANDA and ANDA meeting discussions. The workshop will also highlight innovative science and cutting-edge methodologies in generic drug development.
https://www.fda.gov/drugs/news-events-human-drugs/advancing-generic-drug-development-translating-science-approval-2025-10072025?utm_medium=email&utm_source=govdelivery
FDA Workshop: 10th Annual Clinical Outcome Assessment in Cancer Clinical Trials Workshop
Date: Wed, Oct. 8, 2025 - 1 - 3:30 p.m. ET
The FDA Oncology Center of Excellence (OCE) Patient-Focused Drug Development (PFDD) program welcomes you to the Clinical Outcome Assessment in Cancer Clinical Trials (COA-CCT) 10th annual workshop. Each year, the COA-CCT workshop provides a forum for collaborative and productive multidisciplinary discussions to advance the understanding of the regulatory and scientific issues surrounding the use of patient-reported outcome (PRO) measures in cancer clinical trials. This workshop will review the FDA guidance on core PROs, finalized in 2024, and discuss how these core outcomes have been used to describe patient experience using recent examples from oncology product labeling.
https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fda-workshop-10th-annual-clinical-outcome-assessment-cancer-clinical-trials-workshop-october-8-2025?utm_medium=email&utm_source=govdelivery
FDA/The Osteosarcoma Institute (OSI) Workshop: Advancing Osteosarcoma Drug Development – Connecting Research and Regulatory Pathways for Improved Outcomes
Date: Fri, Oct. 10, 2025; 9:30 a.m. - 5 p.m. ET
The FDA Oncology Center of Excellence (OCE) and The Osteosarcoma Institute (OSI) have a shared interest in engaging with the osteosarcoma community to identify the major barriers to drug development for osteosarcoma and to discuss opportunities for collaboration to address these challenges.
https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fdathe-osteosarcoma-institute-osi-workshop-advancing-osteosarcoma-drug-development-connecting?utm_medium=email&utm_source=govdelivery
Modeling and Artificial Intelligence (AI) in Generic Drug Development and Product Lifecycle Management: Regulatory Insights and Future Trends
Day 1: Wed, Oct. 15, 2025; 8:30 a.m. - 5:10 p.m. ET
Day 2: Thu, Oct. 16, 2025; 8:30 a.m. - 3:40 p.m. ET
Artificial Intelligence (AI) is rapidly transforming drug development and regulatory processes across the pharmaceutical industry. This workshop explores cutting-edge applications of modeling and AI throughout the drug development lifecycle, with particular emphasis on complex generics. Through presentations, panel discussions, and interactive sessions, attendees will examine how AI is being integrated into regulatory frameworks to streamline workflows, accelerate development timelines, and advance quantitative medicine approaches.
https://www.complexgenerics.org/education-training/modeling-and-artificial-intelligence-ai-in-generic-drugs-regulatory-insights-and-future-trends/?utm_medium=email&utm_source=govdelivery
Webinars and Virtual Workshops 1 +...
Advancing the Development of Pediatric Therapeutics (ADEPT) 10: Addressing Challenges in Neonatal Product Development – Leveraging Rare Disease Frameworks
Day 1: Wed, Dec. 10, 2025; 1- 5 p.m. ET
Day 2: Thu, Dec. 11, 2025; 8:30 a.m. - 4:00 p.m. ET
The aim of the public workshop is to discuss common challenges in neonatal and rare disease product development and identify opportunities to leverage rare disease product development frameworks in the neonatal product development space.
https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/advancing-development-pediatric-therapeutics-adept-10-addressing-challenges-neonatal-product?utm_medium=email&utm_source=govdelivery
Pediatric Developmental Safety Assessment: New Approach Methods
Date: Fri, Dec. 5, 2025 - 8 a.m. - 4 p.m. ET
The FDA in collaboration with the Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI) will host a public workshop entitled “Hybrid Public Workshop: Pediatric Developmental Safety Assessment and New Approach Methodologies” on December 5, 2025. The goal of this workshop is to discuss new approach methods that can address pediatric developmental safety during drug development.
https://www.fda.gov/drugs/news-events-human-drugs/pediatric-developmental-safety-assessment-new-approach-methods-12052025?utm_medium=email&utm_source=govdelivery
Virtual Public Meeting and Listening Session on Food Allergen Thresholds and Their Potential Applications
Day 1: Tue, Nov. 18, 2025; 10:45 a.m. - 4 p.m. ET
Day 2: Wed, Nov. 19, 2025; 10 - 11:30 a.m. ET and 2 - 3:30 p.m. ET
Day 3: Thu, Nov. 20, 2025; 10 - 11:30 a.m. ET and 2 - 3:30 p.m. ET
The FDA will host, in collaboration with various stakeholders, including industry, consumer groups, healthcare professionals, individual firms, retailers, and academic researchers, a virtual public meeting followed by virtual listening sessions to help inform the FDA’s next steps, prioritize potential options, and advance our food allergen threshold approaches to benefit public health.
https://www.fda.gov/food/workshops-meetings-webinars-food-and-dietary-supplements/virtual-public-meeting-and-listening-session-food-allergen-thresholds-and-their-potential?utm_medium=email&utm_source=govdelivery
Digital Health Advisory Committee Meeting Announcement
Date: Thu, Nov. 6, 2025; 9 a.m. - 6 p.m. ET
The FDA announces a forthcoming public advisory committee meeting of the Digital Health Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA. The meeting will be open to the public. The FDA is establishing a docket for public comment.
https://www.fda.gov/advisory-committees/advisory-committee-calendar/november-6-2025-digital-health-advisory-committee-meeting-announcement-11062025?utm_medium=email&utm_source=govdelivery
Cheminformatics Resources of U.S. Governmental Organizations 2025 Workshop
Day 1: Wed, Nov. 5, 2025; 9 a.m. - 4:30 p.m. ET
Day 2: Thu, Nov. 6, 2025; 9 a.m. - 4:30 p.m. ET
Day 3: Fri, Nov. 7, 2025; 9 a.m. - 4:30 p.m. ET
The purpose of the Cheminformatics Resources of U.S. Governmental Organizations 2025 Workshop is to enhance communication and collaboration between the U.S. Government-funded organizations that create and maintain databases, data standards, datasets, scientific approaches and computational resources dealing with chemical structures and properties of molecules and materials.
https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/cheminformatics-resources-us-governmental-organizations-2025-workshop-11052025?utm_medium=email&utm_source=govdelivery
Disseminated Coccidioidomycosis: Developing Drugs for Treatment Draft Guidance for Industry September 2025
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/disseminated-coccidioidomycosis-developing-drugs-treatment?utm_medium=email&utm_source=govdelivery
FDA Publishes Draft Guidance on Developing Drugs to Treat Disseminated Coccidioidomycosis (Valley Fever)
The U.S. Food and Drug Administration (FDA) published a draft guidance, “Disseminated Coccidioidomycosis: Developing Drugs for Treatment” on Sept. 17. This guidance provides recommendations for sponsors developing treatments for disseminated coccidioidomycosis (Valley Fever), a serious fungal infection. Symptoms can include fever, cough, chest pain, joint pain, fatigue and night sweats. Disseminated coccidioidomycosis can affect multiple organ systems, e.g., the soft tissue, bone and joint, genital tract, peritoneal, and central nervous system (i.e., meningitis), and can require prolonged treatment.
The guidance addresses clinical trial design, patient population selection, and efficacy endpoints. In particular, the guidance recommends primary efficacy endpoints based on clinical outcome assessments, such as patient-reported outcomes, to capture outcomes that are most meaningful to patients, can be improved with treatment, and are expected to be sufficiently sensitive to detect a treatment effect.
The Development and Use of Office of New Drugs Custom Medical Queries for Safety Analyses of Clinical Trial Data
https://link.springer.com/article/10.1007/s40264-025-01582-1?utm_medium=email&utm_source=govdelivery
FDA Publishes Manuscript on Office of New Drugs Custom Medical Queries for Safety Analysis of Clinical Trial Data
The U.S. Food and Drug Administration’s (FDA) Office of New Drugs (OND) has published a manuscript, “The Development and Use of Office of New Drugs Custom Medical Queries for Safety Analyses of Clinical Trial Data,” in the Drug Safety journal.
OND Custom Medical Queries (OCMQs) are intended to capture clinically meaningful groupings (i.e., safety signals) in premarketing data. OCMQs have become an important component of premarket drug safety evaluations, as they have improved FDA’s ability to detect safety signals and distinguish and quantify adverse reactions in clinical trial data. The use of OCMQs promotes a consistent safety signal detection strategy across OND divisions.
This article provides an overview of the development and use of OCMQs in evaluating premarket drug safety. More information about OCMQs is available here.
https://www.fda.gov/drugs/development-resources/office-new-drugs-custom-medical-queries-ocmqs?utm_medium=email&utm_source=govdelivery
Registration Now Open for FDA-CRCG Workshop: Modeling and Artificial Intelligence (AI) in Generic Drug Development and Product Lifecycle Management
https://www.eventbrite.com/e/modeling-ai-in-generic-drug-development-reg-insights-future-trends-tickets-1550089562609?aff=oddtdtcreator&utm_medium=email&utm_source=govdelivery
Bookmark and Share
Registration Now Open for
FDA-CRCG Workshop: Modeling and Artificial Intelligence (AI) in Generic Drug Development and Product Lifecycle Management
Join the FDA and CRCG for the
Modeling and Artificial Intelligence (AI) in Generic Drug Development and Product Lifecycle Management: Regulatory Insights and Future Trends
on October 15-16, 2025
THIS WORKSHOP IS FREE TO ATTEND VIRTUALLY
Register Now
Get ready to explore the transformative potential of Artificial Intelligence (AI) in pharmaceutical development and regulation. This workshop will delve into the latest applications, challenges, and regulatory considerations of AI throughout the drug development lifecycle.
The workshop will provide comprehensive insights into the evolving role of AI in generic drug development and product lifecycle management. Through a series of presentations, panel discussions, and interactive sessions, attendees will gain a deeper understanding of:
Current regulatory perspectives on AI integration in generic drug development and assessment processes
AI-driven workflow optimization in regulatory writing and product development
Cutting-edge AI applications in drug discovery, formulation, and manufacturing
The intersection of AI with quantitative medicine approaches
Join leading experts from FDA, European Medicines Agency, industry, and academia as we navigate the future of AI in pharmaceutical innovation and regulation. Whether you're a regulatory professional, pharmaceutical scientist, AI specialist, or academic researcher, this workshop offers invaluable insights into the rapidly evolving landscape of AI in generic drug development.
Don't miss this opportunity to shape the future of pharmaceutical innovation!
This workshop will be held virtually and in-person at The Universities at Shady Grove, Rockville, MD.
Register now and get ready to revolutionize your understanding of AI use in generic drug development!
lunes, 29 de septiembre de 2025
NC’s Medicaid ‘HOP’ Experiment Nixed; It ‘Saved My Life,’ One Recipient Says
https://kffhealthnews.org/morning-breakout/ncs-medicaid-hop-experiment-nixed-it-saved-my-life-one-recipient-says/
NC’s Medicaid ‘HOP’ Experiment Nixed; It ‘Saved My Life,’ One Recipient Says
Cancellation of the Healthy Opportunities Pilot, or HOP, has been especially disheartening for residents of Asheville and the surrounding counties, which are still recovering from Hurricane Helene that hit one year ago, The New York Times reported. More stories on Medicaid, SNAP, and hunger are from Maryland, California, Maine, Kansas, and elsewhere.
The New York Times: Fragile N.C. Residents Lose Medicaid Support For Food And Housing
Five years ago, North Carolina embarked on a bold experiment to road test the idea that providing nutritious food, safe housing and transportation for doctors’ visits can help fragile Medicaid recipients stay healthy and avoid costly hospital stays. But the program is shutting down, an early casualty of the cuts to Medicaid that Congress approved in July. (Jacobs, 9/29)
Enlace Latino NC: North Carolina Students Face Reduced Access To Fresh, Local Meals Amid Federal Funding Cuts
At L. Gilbert Carroll Middle School in Robeson County, Principal Zach Jones watches the lunch line carefully, ensuring every student gets a tray. Many arrive hungry; breakfast and lunch at school may be the only meals they can count on. “Every morning, every student comes through and gets a plate for breakfast. Even if they don’t eat it, they can share it. The same goes for lunch. That way our students who we know may have some food insecurities, are getting fed,” he said. (Cotto, 9/28)
More on funding cuts and hunger —
The Baltimore Sun: MD Health Department Accused Of Failing Disabled Residents
A nonprofit organization serving people with intellectual and developmental disabilities has filed a class-action lawsuit against the Maryland Department of Health on behalf of people who say their Medicaid benefits and services were unlawfully terminated. (Schumer, 9/27)
Politico: Republicans Are Making Changes To SNAP And Medicaid. County Officials Say They’re Not Prepared To Handle It
Local officials charged with administering the country’s social safety net said changes in Republicans’ One Big Beautiful Bill Act will tax an already strained system, leading to an untenable workload for underresourced workers and potentially leading some eligible support recipients to fall through the cracks. (Wendler, 9/27)
The Maine Monitor: Maine’s Food Pantries Stare Down Volunteer Shortage While Anticipating Cuts
Phylis Allen spends her days looking for things. She searches for potatoes at Sam’s Club, cheap beets and ginger at Walmart and a local grocery store. She studies the weekly inventory from Good Shepherd, Maine’s only food bank, for good deals on butter and cheese. Every Monday morning, she shops at three different stores, keeping lists of prices in her head and remembering what particular clients want. On a recent trip to Sam’s Club, she was searching for affordable eggs. The diminutive 78-year-old food pantry director found them in a huge cooler. (Appleton Grant, 9/28)
The Beacon: In Rural Kansas, Grocers Face Troubles. One Program Keeps Them Competitive
When visiting his wife’s hometown of 400 in northern Kansas, Bob Lozier would joke with the owners of the grocery store that when they were ready to retire, he’d take over. He didn’t really expect to actually take over the store — but he did. In 2022, the owner of the only grocery store in Axtell decided to sell. The space had served as the town’s store since 1905. Suddenly, the residents of Axtell were facing a future without one. About 40 investors, including Lozier’s wife, came together to raise nearly $500,000 to demolish and rebuild the store. They found more funding through the Kansas Healthy Food Initiative, which provides financial assistance to rural grocers. And Axtell residents donated their labor and skills to finish the project in under a year. (Cunningham and Mesa, 9/26)
KFF Health News: Where Jobs Are Scarce, Over 1 Million People Could Dodge Trump’s Medicaid Work Rules
Millions of Medicaid enrollees may have a way out of the new federal work requirement — if they live in a county with high unemployment. By January 2027, President Donald Trump’s far-reaching domestic policy law will require many adult, nondisabled Medicaid enrollees in 42 states and Washington, D.C., to work or volunteer 80 hours a month or go to school. (Galewitz, 9/29)
Viewpoints: What 25 Years Of Mifepristone In The US Has Brought; Actions That Will Lower Drug Costs
https://kffhealthnews.org/morning-breakout/viewpoints-what-25-years-of-mifepristone-in-the-us-has-brought-actions-that-will-lower-drug-costs/
Viewpoints: What 25 Years Of Mifepristone In The US Has Brought; Actions That Will Lower Drug Costs
Opinion writers discuss these public health issues.
Stat: Celebrating Mifepristone, A Hero In Modern Abortion Access, On Its 25th Anniversary In The U.S.
When the Food and Drug Administration approved mifepristone, the abortion pill, on Sept. 28, 2000, none of us working on expanding access to reproductive health care could have imagined the future we find ourselves in 25 years later. From the fall of Roe in 2022 and the subsequent banning or restriction of abortion in 19 states, to South Carolina’s recent efforts to include some forms of birth control in its total abortion ban, access to the basic medical care and medications that allow us to control our reproductive destinies is hanging by a thread. In the midst of this reproductive health care apocalypse, mifepristone is proving itself to be a hero in the fight for abortion access. (Elisa Wells, 9/28)
The Washington Post: How Big Pharma Wants To Lower Drug Prices
The biopharmaceutical industry is responding to Trump’s call to put America first by announcing three major actions to lower drug costs for patients, protect medical innovation and strengthen the nation’s leadership in life sciences. (Steve Ubl, 9/29)
St. Louis Post-Dispatch: Trump Cuts Food Program — Then Cuts Hunger Survey. It’s Part Of A Pattern.
President Donald Trump’s “Big Beautiful Bill” is anything but for the nation’s poorest families. Among the numerous cruel elements to the new spending plan are food-program cuts that are expected to increase “food insecurity” — also known as hunger — for millions of Americans, including children. What terrible optics going into the midterm election season. But no worries. Trump’s administration this month announced how it intends to address the politically inconvenient specter of coddling billionaires at the expense of impoverished Americans who will go hungry: It’s ending the longstanding hunger survey that counts them. (9/28)
The Boston Globe: Trump Blames Pregnant Women For Autism
The Trump administration’s targeting of women’s behavior as the basis for autism evokes the disgraceful mid-20th-century era of so-called refrigerator mothers, when the medical establishment widely believed and falsely claimed that autism in children was caused by cold and emotionally distant mothers. (Renee Graham, 9/28)
Stat: How The FDA Can Bring More Medicine Manufacturing To The U.S.
America’s role in advancing science, investing in domestic manufacturing, and protecting public health is at a pivotal moment. Scientific discoveries are creating unprecedented opportunities, and the choices government agencies make today will determine how quickly those innovations reach patients. By modernizing how we develop and manufacture lifesaving therapies here at home, we can bet on ourselves and accelerate delivery to the people who need them most. (Jeffrey Francer and Victor Cruz, 9/29)
Wyoming Maternity Desert Grows As Another County Stops L&D Services
https://kffhealthnews.org/morning-breakout/wyoming-maternity-desert-grows-as-another-county-stops-ld-services/
Wyoming Maternity Desert Grows As Another County Stops L&D Services
When Banner Platte County Hospital pauses inpatient labor and delivery services in October, nine Wyoming counties won't have obstetric care. Other news from around the nation is about an abortion bill in Ohio, Lilly's fifth ‘gateway’ lab in California, and more.
Wyoming Public Radio: Wyoming Maternal Health Care Shrinks As Platte County Pauses Labor And Delivery Services
Another county will become a maternal health care desert in the state on Oct. 15. Banner Platte County Hospital announced this week that it will be pausing inpatient labor and delivery services this fall. That includes newborn patient care, postpartum care and outpatient prenatal care. (Kudelska, 9/26)
Today in Ohio: Ohio GOP Lawmakers Defy Voters With New Abortion Bill Despite Constitutional Amendment
The latest legislative maneuver, House Bill 347—ironically titled “SHE Wins” (Share Health and Empower with Informed Notices)—would require a 24-hour waiting period before abortions and mandate that doctors provide detailed information about the procedure, risks, and alternatives like adoption. (9/28)
More health news from across the U.S. —
The San Diego Union-Tribune: Lilly Opens Fifth ‘Gateway’ Lab On Torrey Pines Mesa
Capable of housing up to 15 up-and-coming biotechnology companies simultaneously, Lilly's fifth ‘gateway’ lab on Torrey Pines Mesa follows similar hubs in San Francisco, Boston and Beijing. (Sisson, 9/26)
AP: States Struggle With AI Therapy App Rules Amid Mental Health Needs
In the absence of stronger federal regulation, some states have begun regulating apps that offer AI “therapy” as more people turn to artificial intelligence for mental health advice. But the laws, all passed this year, don’t fully address the fast-changing landscape of AI software development. And app developers, policymakers and mental health advocates say the resulting patchwork of state laws isn’t enough to protect users or hold the creators of harmful technology accountable. (Shastri, 9/29)
KFF Health News: States Target Ultraprocessed Foods In Bipartisan Push
California Republican James Gallagher, the GOP’s former Assembly leader, has often accused the state’s progressive lawmakers of heavy-handed government intrusion, but this year he added his name to a legislative push for healthier school meals. His party followed suit, with all but one Republican voting to send a bill to Democratic Gov. Gavin Newsom that would put into law a first-in-the nation legal definition of ultraprocessed foods, followed by a public school ban on those deemed most concerning. (Boyd-Barrett, 9/29)
Summer Covid Surge Is Ebbing, Though ED Visits Are Highest For Kids Under 4
https://kffhealthnews.org/morning-breakout/summer-covid-surge-is-ebbing-though-ed-visits-are-highest-for-kids-under-4/
Summer Covid Surge Is Ebbing, Though ED Visits Are Highest For Kids Under 4
Wastewater sampling shows that the Northeast has the highest level of infections in the U.S. Plus, updates on the 2024-25 flu season, this year's flu vaccine makeup, various food recalls, and more.
CIDRAP: US COVID Declining After Reaching Peak
COVID activity has peaked and is now on a downward trend in many regions of the country, though emergency department (ED) visits and hospitalizations are still elevated, the Centers for Disease Control and Prevention (CDC) said today in its latest update. The current COVID wave began in June, marked by a slow rise that never approached levels seen last summer. (Schnirring, 9/26)
CIDRAP: Nearly 7 In 10 COVID Survivors Tested Didn't Know They Had A Dulled Sense Of Smell
Even if they don't notice it, COVID-19 survivors' sense of smell may remain impaired for years after infection, the Researching COVID to Enhance Recovery (RECOVER) Consortium reported yesterday in JAMA Network Open. The RECOVER-Adult study surveyed adults with and without previous SARS-CoV-2 infection about their symptoms roughly every 90 days from October 2021 to June 2025. (Van Beusekom, 9/26)
On influenza, avian flu, and hep B —
CIDRAP: CDC Reports Highlight 2024-25 Flu Season's Deadly Impact On US Kids
Two new reports this week from the Centers for Disease Control and Prevention (CDC) provide more detail on the deadliest flu season for US children in more than a decade. The reports, published yesterday in Morbidity and Mortality Weekly Report (MMWR), include data on the 280 US children who died during the 2024-25 flu season, along with information on 109 children who died from a rare and severe neurologic complication of flu during the season. (Dall, 9/26)
CIDRAP: WHO Replaces H1N1 And H3N2 Strains For Southern Hemisphere Flu Vaccines
The World Health Organization (WHO) today announced its advisory group’s recommendations for the Southern Hemisphere’s 2026 flu vaccines, which swap out both the H1N1 and H3N2 strains in the current vaccines for the Northern Hemisphere as well as those for the Southern Hemisphere’s last flu season. (Schnirring, 9/26)
Medical Xpress: Inactive H5N1 Influenza Virus In Pasteurized Milk Poses Minimal Health Risks
Proteins and genetic material from H5N1 influenza viruses have been found in pasteurized milk in the United States, but a study from St. Jude Children's Research Hospital shows those inactive viral pieces represent little to no health risk. (9/27)
CIDRAP: Los Angeles Cat H5N1 Deaths Prompt New Warning About Raw Pet Food
The Los Angeles Department of Public Health (LADPH) yesterday issued an animal health alert, following the severe illnesses and deaths of two indoor-only cats from the same household after eating commercially sold raw pet food. In a statement, county veterinary officials said one of the cats tested positive for highly pathogenic H5N1 that belongs to the B3.13 genotype, which has been circulating in US dairy cows as well as in poultry. The second cat was not available for testing. (Schnirring, 9/26)
KFF Health News: In Hepatitis B Vaccine Debate, CDC Panel Sidesteps Key Exposure Risk
The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children. This comes despite a failed attempt to do so at the most recent meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. Both President Donald Trump and some newly appointed ACIP members have mischaracterized how the liver disease spreads, according to medical experts, including those working at the CDC. (Fortiér, 9/29)
In recalls —
AP: After Massive Shrimp Recalls, The FDA Finds Radioactive Contamination In Spices Too
U.S. Food and Drug Administration officials last week blocked import of all spices from PT Natural Java Spice of Indonesia after federal inspectors detected cesium 137 in a shipment of cloves sent to California. That follows the import alert imposed in August on the company PT Bahari Makmuri Sejati, or BMS foods, which sends millions of pounds of shrimp to the U.S. each year. (Aleccia, 9/26)
AP: Listeria In Walmart, Trader Joe's Meals May Be Linked To Outbreak
Federal health officials are warning consumers not to eat certain heat-and-eat pasta meals sold at Walmart and Trader Joe’s because they may be contaminated with listeria bacteria previously linked to a deadly outbreak. The U.S. Agriculture Department updated a public health alert Friday to include Trader Joe’s Cajun Style Blackened Chicken Breast Fettucine Alfredo sold in 16-ounce plastic trays. (Aleccia, 9/27)
AP: Albertsons Recalls Some Deli Items Due To Potential Listeria Contamination
Albertsons Companies has recalled several of its store-made deli products because they may contain listeria bacteria, in a move that arrives shortly after federal health officials warned consumers to not eat certain pasta meals sold at Walmart and Trader Joe’s over similar contamination concerns. The Boise, Idaho-based supermarket giant on Saturday said it was pulling five deli items because they contain a recalled bowtie pasta ingredient made by Nate’s Fine Foods. (9/28)
AP: 58 Million Pounds Of Corn Dogs, Sausage-On-A-Stick Products Recalled
About 58 million pounds of corn dogs and other sausage-on-a-stick products are being recalled across the U.S. because pieces of wood may be embedded in the batter, with several consumers reporting injuries to date. According to a Saturday notice published by the Agriculture Department’s Food Safety and Inspection Service, the recall covers select “State Fair Corn Dogs on a Stick” and “Jimmy Dean Pancakes & Sausage on a Stick” products from Texas-based Hillshire Brands, which is a subsidiary of Tyson Foods. (9/28)
Gunman Who Killed 4 At Manhattan Office Building Had CTE, Coroner Finds
https://kffhealthnews.org/morning-breakout/gunman-who-killed-4-at-manhattan-office-building-had-cte-coroner-finds/
Gunman Who Killed 4 At Manhattan Office Building Had CTE, Coroner Finds
In other news about the gun violence epidemic, the suspects in two separate mass shootings over the weekend in North Carolina and Michigan are both military veterans who had served in war zones.
The New York Times: Gunman In NYC Shooting At NFL Headquarters Had CTE
The gunman who killed four people in a Midtown Manhattan office building in July had chronic traumatic encephalopathy, the degenerative brain disease linked to repeated head injuries sustained in football and other contact sports, according to the New York City medical examiner’s office. The disease, known as C.T.E., can be diagnosed only posthumously. Shane Tamura, the gunman, killed himself after the shooting spree at 345 Park Avenue. (Belson and Marcius, 9/26)
NBC News: What We Know About Thomas Jacob Sanford, The Suspect In The Michigan Church Shooting
The person accused in a fatal shooting and fire Sunday at a Church of Jesus Christ of Latter-day Saints in Grand Blanc Township, Michigan, is a 40-year-old area man with a military background. Officers killed Thomas Jacob Sanford in a parking lot behind the church, police said. Sanford joined the Marine Corps in 2004. He was awarded the Marine Corps Good Conduct Medal, the Sea Service Deployment Ribbon, the Iraq Campaign Medal, the Global War on Terrorism Service Medal and the National Defense Service Medal, records show. (Romero, 9/28)
NBC News: 'Highly Premeditated' Attack At North Carolina Waterfront Bar Leaves 3 Dead And 5 Wounded
A lone gunman killed three people and injured five others at a packed North Carolina waterfront bar late Saturday in what police described as a “highly premeditated” attack. Nigel Max Edge, 40, was detained by the Coast Guard and charged with three counts of first-degree murder, five counts of attempted murder and five counts of assault with a deadly weapon on Sunday morning. Southport Police Chief Todd Coring told reporters that Edge is a “self-described” combat veteran who was injured in the line of duty and suffers from post-traumatic stress disorder. Edge served in the Marines from September 2003 through June 2009, according to military records. He attained the rank of sergeant and was deployed twice as part of Operation Iraqi Freedom. (Madani, Gilchrist and Gallo, 9/28)
Governing: Illinois Considers Unusual Approach To Gun Regulations
An Illinois bill proposes a novel approach to gun regulation and gun violence prevention. The Responsibility in Firearm Legislation (RIFL) Act, if passed, would subject firearm manufacturers to a variable licensing fee: The more often their guns are found to have been used in injury-causing incidents, the higher their fee. The money would go toward compensating gun violence victims or to cover other costs associated with gun violence. (Pattison-Gordon, 9/29)
ACA Subsidies Remain A Sticking Point As Government Shutdown Draws Nigh
https://kffhealthnews.org/morning-breakout/aca-subsidies-remain-a-sticking-point-as-government-shutdown-draws-nigh/
ACA Subsidies Remain A Sticking Point As Government Shutdown Draws Nigh
Democrats are pressing for the extension of subsidies in the GOP-backed continuing resolution to fund the government. Republicans stand firm in putting off those negotiations until later. Top lawmakers from both parties are set to meet with the president today.
The Hill: Lawmakers Dig In Heels As Shutdown Deadline Looms
Lawmakers from both parties dug in their heels Sunday over government funding demands ahead of a meeting between President Trump and congressional leaders aimed at averting a shutdown this week. During various interviews on the Sunday political affairs programs, Republican and Democratic leaders signaled that health care subsidies set to expire at the end of the year remain a key sticking point. (Fortinsky, 9/28)
The Washington Post: Extra Obamacare Subsidies Are At The Heart Of Government Shutdown Battle
The fight over covid-era health insurance subsidies that could trigger a government shutdown highlights what even supporters of the Affordable Care Act fight admit is a flaw in the original law: It wasn’t generous enough to make plans affordable. Democrats want to keep providing extra subsidies to enroll in plans offered through the ACA. But Republicans who control Congress say that it’s time to scale back because the pandemic is over. (Winfield Cunningham, 9/28)
Politico: Schumer Pushes For ‘Real’ Negotiations Ahead Of White House Meeting
Senate Minority Leader Chuck Schumer is urging Republicans to come to the table for “real” government funding negotiations, a day before congressional leaders will meet with President Donald Trump. “The meeting is a first step, but only a first step. We need a serious negotiation,” Schumer said during an interview with NBC’s “Meet the Press” with host Kristen Welker. (Carney, 9/28)
The Hill: Van Hollen Says Democrats ‘Not Going To Write A Blank Check’ To Avert Shutdown
Sen. Chris Van Hollen (D-Md.) said Democrats will not “write a blank check” to the Trump administration to avert a government shutdown. In a Sunday interview on CNN’s “State of the Union,” the Maryland Democrat doubled down on the party’s opposition to a GOP-backed continuing resolution (CR) to extend government funding at current levels unless money is included for health insurance subsidies under the Affordable Care Act that are set to expire at the end of the year. (Fortinsky, 9/28)
KFF Health News: Journalists Recap Coverage On Organ Harvesting, Obamacare, And Medicaid Cuts
KFF Health News Midwest correspondent Cara Anthony discussed problems with the organ transplantation industry on Apple News’ “Apple News Today” on Sept. 23. ... KFF Health News senior correspondent Julie Appleby discussed the changing availability of Affordable Care Act plans on Wisconsin Public Radio’s “Wisconsin Today” on Sept. 19. (9/27)
In other news from Capitol Hill —
Modern Healthcare: Medicare To Cover Breakthrough Devices Faster Under House Bill
Medicare beneficiaries could get faster access to cutting-edge medical technology as a result of a bill that advanced through the House Ways and Means Committee. The medical device trade association AdvaMed, along with 67 stakeholders including patient advocacy groups and state medtech and life sciences associations, have pushed for the measure. It takes 5.7 years on average for medical devices granted Food and Drug Administration breakthrough device designation to receive Medicare coverage. Private insurers typically follow Medicare’s lead. (Dubinsky, 9/26)
4 Million People May Lose Housing Assistance Under New Trump Plan
https://kffhealthnews.org/morning-breakout/4-million-people-may-lose-housing-assistance-under-new-trump-plan/
4 Million People May Lose Housing Assistance Under New Trump Plan
ProPublica obtained drafts of unpublished rules that could lead to work requirements, time limits on living in federally supported housing, and more. Other administration news is on visa fees, foreign aid, tariffs, and drug prices.
ProPublica: Millions Could Lose Housing Aid Under Trump Plan
Some 4 million people could lose federal housing assistance under new plans from the Trump administration, according to experts who reviewed drafts of two unpublished rules obtained by ProPublica. The rules would pave the way for a host of restrictions long sought by conservatives, including time limits on living in public housing, work requirements for many people receiving federal housing assistance and the stripping of aid from entire families if one member of the household is in the country illegally. The first Trump administration tried and failed to implement similar policies, and renewed efforts have been in the works since early in the president’s second term. (Coburn, 9/29)
On visa fees and foreign aid—
The New York Times: Medical Groups Warn Against Visa Fees For Foreign Doctors
The American Medical Association and scores of specialty groups are urging the Trump administration to exempt foreign doctors from steep new fees for H-1B visas, saying the charges will exacerbate physician shortages, worsen patient care and drive up health care costs. Doctors from abroad make up nearly one quarter of the physician work force in the United States. (Caryn Rabin, 9/26)
Bloomberg: Mozambique: US Pledges $160 Million HIV And TB Aid
The US pledged $160 million in interim assistance for HIV and tuberculosis testing and treatment in Mozambique, after months of uncertainty triggered by a foreign aid review in January that led to the closure of the US Agency for International Development. The funding will be used in some of the programs that were covered under the President’s Emergency Plan for AIDS Relief (Pepfar), the US initiative that provided life-saving HIV treatment across 55 countries and is estimated to have saved 26 million lives globally. (Cebola, 9/26)
On tariffs and drug prices —
The New York Times: Trump’s Pharma Tariffs Spare Richest Drugmakers
Mr. Trump’s 100 percent tariff, expected to go into effect on Oct. 1, would not apply to drugs imported from the European Union. Instead, most of those brand-name products from the European Union are expected to be hit by a tariff of up to 15 percent secured as part of a trade deal over the summer. It was not immediately clear when that will take effect. However, big drugmakers like Roche, Novartis and AstraZeneca do some manufacturing in their home countries of Switzerland and Britain, which are not part of the European Union. (Robbins and Swanson, 9/26)
The New York Times: How Trump’s Latest Tariffs May Affect Your Medicines
For months, as President Trump threatened to impose punishing tariffs on imported medicines, fears mounted that American patients would be harmed by higher prices and shortages of vital drugs. The details of the drug tariffs Mr. Trump announced on Thursday night are still coming into focus. (Robbins, 9/26)
The Wall Street Journal: Drug Tariffs Are A Sideshow. Trump’s Next Move Could Hit Pharma Harder.
It’s becoming increasingly clear that pharmaceutical companies can live with President Trump’s tariffs. What the industry can’t live with is uncertainty on drug prices. The sector has long traded at a discount to the broader market, but that gap has widened to its largest in decades as investors fret over Trump’s policies—ranging from tariffs and price controls to the unpredictable influence of Health and Human Services Secretary Robert F. Kennedy Jr. (Wainer, 9/27)
The Wall Street Journal: Luring U.S. Drugmakers Back From This Irish Outpost Won’t Be Easy
The arrival of what locals here call the “Pfizer riser” helped put this Irish coastal village on the map. When the U.S. pharma giant started making the ingredients for the erectile dysfunction drug Viagra in a factory here a few decades ago, the international media flocked to this small cluster of pebble-dashed houses. (Colchester, 9/27)
Trump Issues New Tylenol Warning: Do Not Give It To Kids For ‘Any Reason’
https://kffhealthnews.org/morning-breakout/trump-issues-new-tylenol-warning-do-not-give-it-to-kids-for-any-reason/
Trump Issues New Tylenol Warning: Do Not Give It To Kids For ‘Any Reason’
The American Academy of Pediatrics maintains acetaminophen is safe for children over 12 weeks old to treat fevers. Also, the National Institutes of Health is launching the Autism Data Science Initiative, which will award $50 million to projects looking for the cause of autism.
Bloomberg: Trump Ratchets Up Pressure On Tylenol With Warning For Kids
President Donald Trump on Friday intensified his campaign against Tylenol to include young kids, posting on his Truth Social that parents shouldn’t give children the drug “for virtually any reason” without providing scientific evidence for the claim. Tylenol — and the active ingredient acetaminophen — is safe for young children to use to treat fevers, according to the American Academy of Pediatrics. Children under 12 weeks old should not be given acetaminophen unless directed by a doctor, the AAP said. (Nix, 9/26)
ABC News: NIH To Spend $50M On Autism Cause Studies, Experts Say US Should Focus On Treatments
In the wake of the White House's announcement of a potential link between acetaminophen use in pregnancy and autism, the administration also unveiled the launch of the Autism Data Science Initiative (ADSI). Under the National Institutes of Health (NIH), the initiative will award $50 million to about a dozen projects looking at finding the causes of autism and improving outcomes for autistic individuals. (Kekatos, 9/26)
The Conversation: Acetaminophen Use During Pregnancy Not Linked To Autism, Our Study Of 2.5 Million Children Shows
United States President Donald Trump recently claimed that using the common painkiller acetaminophen (also known as paracetamol and by the brand name Tylenol in the US) during pregnancy is fueling the rise in autism diagnoses. He then went on to suggest pregnant women should “tough it out” rather than use the common painkiller if they experience fever or pain. (Gardner, Lee and Ahlqvist, 9/28)
CNN: In Doctors’ Offices, The Consequences Of Trump’s Comments On Tylenol And Vaccines Are Immediately Clear
Hours after President Donald Trump’s announcement linking acetaminophen use during pregnancy with autism in children, a mother sat in my office, sobbing. Had she caused her child’s autism by treating the debilitating headaches she suffered while she was pregnant? (Bracho-Sanchez, 9/26)
NBC News: Before Trump Touted The Drug Leucovorin For Autism, These Families Had Already Tried It
Last winter, Brian Noonan read online that some doctors were prescribing an obscure drug, typically given to cancer patients, for autism. Curious, he looked into it for his son Benjamin, who had just been diagnosed with autism in October. “We jumped on it,” Noonan said. “It felt right and it made sense.” The medication was leucovorin, also called folinic acid. It’s a synthetic form of vitamin B9 or folate, which the body needs to make healthy blood cells. During pregnancy, folate is important to reduce the risk of birth defects. (Lovelace Jr., 9/28)
The Wall Street Journal: Trump Is Betting That Stance On Vaccines, Autism And Tylenol Will Rally His MAGA Base
Jennifer Foskey, who has a 12-year-old daughter with autism, eagerly voted for President Trump last fall for the third time. When he labeled Tylenol use by pregnant women as a potential cause of autism on Monday, she felt a mixture of guilt and shock. “I’ve had four pregnancies, and I’ve taken Tylenol with all of them, just for all the aches and pains that come along with being pregnant,” the Jacksonville, Fla., homemaker said. “So I thought, was this my fault?” (Andrews and Li, 9/27)
domingo, 28 de septiembre de 2025
5 Key Facts About Medicaid Coverage for People With Intellectual and Developmental Disabilities (I/DD) Authors: Priya Chidambaram, Alice Burns, and Abby Wolk Published: Sep 22, 2025
https://www.kff.org/medicaid/5-key-facts-about-medicaid-coverage-for-people-with-intellectual-and-developmental-disabilities-idd/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--1Q-OaOOpWb_J3NfW6wrKFRJfePly7b8PAPL3uQ-nmOwpK7hNwaG5NNRIxVN5C0R4dvitg2YXB0mi08fIi1cBy3UvY8g&_hsmi=382448570&utm_content=382448570&utm_source=hs_email
The Impact of H.R. 1 on Two Medicaid Eligibility Rules
Authors: Anna Mudumala, Maiss Mohamed, Jennifer Tolbert, and Alice Burns
Published: Sep 22, 2025
https://www.kff.org/medicaid/the-impact-of-h-r-1-on-two-medicaid-eligibility-rules/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-8wRR8o66wZ0QBTC_3khE65xYbzpwB1ej4HMhTV5Ln8TlGEvm0BFerYExKv2Bjvpi230yXJOPUukNmb_cm2nuW0mhAzaw&_hsmi=382448570&utm_content=382448570&utm_source=hs_email
Big Loopholes in Hospital Charity Care Programs Mean Patients Still Get Stuck With the Tab By Michelle Andrews September 25, 2025
Big Loopholes in Hospital Charity Care Programs Mean Patients Still Get Stuck With the Tab
Even if people qualify for financial help with their hospital bills, the care they receive may not be covered.By Michelle Andrews
September 25, 2025
https://kffhealthnews.org/news/article/hospital-charity-care-loopholes-needy-patients-pay/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_LzMT72pcaoVBpCBc8hgLMLUby6e76NA_Gx1GJIs7c7gNdxpIKiG1uz-W8SAxqDYKP-AyDXvX9R4QSCVUtsqjJo13q5g&_hsmi=382448570&utm_content=382448570&utm_source=hs_email
Occupations with Large Shares of Workers Who Rely on Individual Market Coverage Authors: Cynthia Cox and Gary Claxton Published: Sep 25, 2025
Occupations with Large Shares of Workers Who Rely on Individual Market Coverage
Authors: Cynthia Cox and Gary Claxton
Published: Sep 25, 2025
https://www.kff.org/affordable-care-act/occupations-with-large-shares-of-workers-who-rely-on-individual-market-coverage/
Tracking State Actions on Vaccine Policy and Access Authors: Jennifer Kates, Clea Bell, Josh Michaud, Elizabeth Williams, and Jennifer Tolbert Published: Sep 24, 2025
https://www.kff.org/covid-19/tracking-state-actions-on-vaccine-policy-and-access/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--jFw6ich0D6Z0SEOljyxICTc3IlTA9cvyk2z6EdvJ1s8Vd667tNspqZiNsoWF-hgkMFywggSSI0CN8GJ6MVQl0gVhrhg&_hsmi=382448570&utm_content=382448570&utm_source=hs_email
Tracking State Actions on Vaccine Policy and Access
With recent federal actions to curtail vaccine access, many states have announced actions intended to maintain broader access. A new issue brief provides a snapshot of this rapidly changing landscape, tracking which states have instituted changes in response to or in anticipation of administration policy changes.
Additionally, KFF's The Monitor explores findings from the KFF-Washington Post Survey of Parents on views of childhood vaccines, and how the Advisory Committee on Immunization Practices (ACIP) may have contributed to concerns about hepatitis B and COVID-19 vaccines.
https://www.kff.org/other-health/new-kff-washington-post-poll-explores-parents-vaccine-attitudes-and-confusion-follows-acip-meeting-on-vaccine-recommendations/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--jXNLrcQuYbat9uefLO1gcdcBA2MPXeVuU4NQD8lFU6f_H63wNS2_3xB_xvnmCJBLMnmP8H5kQpbM9r4GdS_4ESHSz_g&_hsmi=382448570&utm_content=382448570&utm_source=hs_email
And more: KFF Health News covered scientists' views of how Trump distorts facts on autism, Tylenol, and vaccines and how states are trying to "restore trust."
‘Sick to My Stomach’: Trump Distorts Facts on Autism, Tylenol, and Vaccines, Scientists Say
By Amy Maxmen
September 22, 2025
https://kffhealthnews.org/news/article/trump-autism-announcement-rfk-tylenol-pregnancy-vaccines/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-99YBbiLbJLCo7Ha2olF_QOThPjhGBrdAAQnsKYRqzoA0Sl17sPPw1oSKkQxtzXPnaeMElfjxonywRZXmSzZV-01ufVlw&_hsmi=382448570&utm_content=382448570&utm_source=hs_email
Amid Confusion Over US Vaccine Recommendations, States Try To ‘Restore Trust’
By Céline Gounder
September 24, 2025
https://kffhealthnews.org/news/article/vaccines-states-hhs-cdc-acip-recommendations-rfk/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-8Mz7NS25Jhf8GCmEdrLsWtjOjKZqTb-gMU-jK5X1f4zbMMnGbDJuWnmiilWq6dQlItlEA2TXBlQlpdB2xF_iJ5r2eLfw&_hsmi=382448570&utm_content=382448570&utm_source=hs_email
Suscribirse a:
Comentarios (Atom)
.png)
